Hypothesis: Temporal SASP miRNA Isoform Switch Determines Senescent Cell Chaperone versus Pathomorphogenic Function

Core Idea

Senescent cells release distinct microRNA (miRNA) isoforms via exosomes that depend on the duration and stress context of senescence. Acute senescent fibroblasts load exosomes with miR-21-5p, which promotes transient myofibroblast differentiation and matrix deposition needed for wound closure. Chronic senescent fibroblasts, under persistent oxidative stress, shift exosomal sorting toward miR-21-3p, which suppresses PTEN and sustains fibroblast survival, driving pathological fibrosis. Therefore, senolytic clearance removes both beneficial and harmful miRNA signals, explaining why timing of senolytic intervention critically influences tissue outcomes.

Mechanistic Reasoning

• p38 MAPK-dependent sorting: In acute wound healing, transient p38 activation in senescent fibroblasts phosphorylates hnRNPA2B1, favoring loading of miR-21-5p into exosomes (see mechanism in embryo development senescence)[https://www.cnio.es/en/news/publications/senescence-also-plays-a-role-in-embryo-development/].
• Chronic oxidative stress: Persistent ROS activates NKRF, altering hnRNPA2B1 affinity and promoting sorting of the miR-21-3p isoform, which targets PTEN 3'-UTR, leading to AKT activation and fibroblast resistance to apoptosis (consistent with chronic fibrosis data)[https://doi.org/10.1007/s11357-022-00551-1].
• Functional switch: miR-21-5p-rich exosomes increase alpha-SMA expression in neighboring fibroblasts for a limited window (~48 h), whereas miR-21-3p-rich exosomes maintain alpha-SMA and collagen I expression beyond 7 days, fostering a stiffened matrix.

Testable Predictions

1. Exosome miRNA profiling: Isolating exosomes from senescent fibroblasts derived from young (acute wound) vs old (chronic fibrosis) mice will show a significant enrichment of miR-21-5p in the young set and miR-21-3p in the old set (p < 0.01, n = 5 per group).
2. Loss-of-function: AntagomiR-21-5p administered during acute wound healing will delay closure without increasing fibrosis, whereas antagomiR-21-3p in aged mice will reduce collagen deposition and improve tensile strength after injury.
3. Senolytic timing: Treating young mice with a senolytic immediately after wounding will impair healing (due to loss of miR-21-5p exosomes); delaying senolytic administration until day 5 post-wound will improve resolution of fibrosis without affecting closure rate.
4. Rescue: Adding synthetic miR-21-5p-loaded exosomes to senolytic-treated wounds will restore normal closure kinetics, while miR-21-3p-loaded exosomes will exacerbate fibrosis in chronic injury models.

Experimental Approach (brief)

• Generate senescent fibroblasts via irradiation (2 Gy) for acute model or chronic low-dose ROS (10 uM H2O2) for 14 days.
• Collect conditioned medium, isolate exosomes by ultracentrifugation, perform small-RNA-seq.
• Validate miRNA isoform specificity by qPCR using stem-loop primers.
• Functional assays: treat naive fibroblasts with exosomes, measure alpha-SMA, collagen I, PTEN, p-AKT.
• In vivo: full-thickness excisional wounds on 8-week-old and 20-month-old mice; administer navitoclax (senolytic) or vehicle; deliver antagomiRs or exosome mimics via hydrogel.
• Endpoints: wound area over time, histology (Masson's trichrome), hydroxyproline content, tensile testing.

Falsifiability

If exosome miRNA isoform composition does not differ between acute and chronic senescent fibroblasts, or if modulating miR-21-5p/miR-21-3p fails to recapitulate the predicted effects on fibroblast phenotype and wound outcomes, the hypothesis would be refuted.

Broader Implication

This reframes senolytics not as blunt removal of "bad" cells but as timed modulation of a secreted regulatory layer, suggesting that therapeutic success depends on preserving the acute chaperone signal while attenuating the chronic pathologic signal.